Target Gene/Pathway💬 Info on mouse-over
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related |
KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
1 | Alcoholism 💬 28 genes, 69 drugs (DrugBank) and 52 diseases |
ADORA2A [1] ADORA2A 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
2 | Alcoholism 💬 28 genes, 69 drugs (DrugBank) and 52 diseases |
ADORA2B [1] ADORA2B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
3 | Alcoholism 💬 28 genes, 69 drugs (DrugBank) and 52 diseases |
ADORA2B [1] ADORA2B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
4 | Alcoholism 💬 28 genes, 69 drugs (DrugBank) and 52 diseases |
ADORA2B [1] ADORA2B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
5 | Alcoholism 💬 28 genes, 69 drugs (DrugBank) and 52 diseases |
ADORA2B [1] ADORA2B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
6 | Aldosterone synthesis and secretion 💬 18 genes, 34 drugs (DrugBank) and 64 diseases |
PDE2A [1] PDE2A 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
7 | Aldosterone synthesis and secretion 💬 18 genes, 34 drugs (DrugBank) and 64 diseases |
PDE2A [1] PDE2A 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
8 | Aldosterone synthesis and secretion 💬 18 genes, 34 drugs (DrugBank) and 64 diseases |
PDE2A [1] PDE2A 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
9 | Aldosterone synthesis and secretion 💬 18 genes, 34 drugs (DrugBank) and 64 diseases |
PDE2A [1] PDE2A 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
10 | Aldosterone synthesis and secretion 💬 18 genes, 34 drugs (DrugBank) and 64 diseases |
PDE2A [1] PDE2A 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
11 | Apelin signaling pathway 💬 12 genes, 26 drugs (DrugBank) and 66 diseases |
PDE3B [1] PDE3B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
12 | Apelin signaling pathway 💬 12 genes, 26 drugs (DrugBank) and 66 diseases |
PDE3B [1] PDE3B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
13 | Apelin signaling pathway 💬 12 genes, 26 drugs (DrugBank) and 66 diseases |
PDE3B [1] PDE3B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
14 | Apelin signaling pathway 💬 12 genes, 26 drugs (DrugBank) and 66 diseases |
PDE3B [1] PDE3B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
15 | Apelin signaling pathway 💬 12 genes, 26 drugs (DrugBank) and 66 diseases |
PDE3B [1] PDE3B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
16 | Calcium signaling pathway 💬 74 genes, 175 drugs (DrugBank) and 126 diseases |
ADORA2A [4] ADORA2A, PDE1A, PDE1B, PDE1C 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
17 | Calcium signaling pathway 💬 74 genes, 175 drugs (DrugBank) and 126 diseases |
ADORA2B [4] ADORA2B, PDE1A, PDE1B, PDE1C 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
18 | Calcium signaling pathway 💬 74 genes, 175 drugs (DrugBank) and 126 diseases |
ADORA2B [4] ADORA2B, PDE1A, PDE1B, PDE1C 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
19 | Calcium signaling pathway 💬 74 genes, 175 drugs (DrugBank) and 126 diseases |
ADORA2B [4] ADORA2B, PDE1A, PDE1B, PDE1C 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
20 | Calcium signaling pathway 💬 74 genes, 175 drugs (DrugBank) and 126 diseases |
ADORA2B [4] ADORA2B, PDE1A, PDE1B, PDE1C 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
21 | cAMP signaling pathway 💬 63 genes, 157 drugs (DrugBank) and 108 diseases |
ADORA1 [9] ADORA1, ADORA2A, PDE10A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
22 | cAMP signaling pathway 💬 63 genes, 157 drugs (DrugBank) and 108 diseases |
ADORA1 [8] ADORA1, PDE10A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
23 | cAMP signaling pathway 💬 63 genes, 157 drugs (DrugBank) and 108 diseases |
ADORA1 [8] ADORA1, PDE10A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
24 | cAMP signaling pathway 💬 63 genes, 157 drugs (DrugBank) and 108 diseases |
ADORA1 [8] ADORA1, PDE10A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
25 | cAMP signaling pathway 💬 63 genes, 157 drugs (DrugBank) and 108 diseases |
ADORA1 [8] ADORA1, PDE10A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
26 | cGMP-PKG signaling pathway 💬 45 genes, 108 drugs (DrugBank) and 112 diseases |
ADORA1 [4] ADORA1, PDE2A, PDE3A, PDE3B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
27 | cGMP-PKG signaling pathway 💬 45 genes, 108 drugs (DrugBank) and 112 diseases |
ADORA1 [4] ADORA1, PDE2A, PDE3A, PDE3B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
28 | cGMP-PKG signaling pathway 💬 45 genes, 108 drugs (DrugBank) and 112 diseases |
ADORA1 [4] ADORA1, PDE2A, PDE3A, PDE3B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
29 | cGMP-PKG signaling pathway 💬 45 genes, 108 drugs (DrugBank) and 112 diseases |
ADORA1 [4] ADORA1, PDE2A, PDE3A, PDE3B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
30 | cGMP-PKG signaling pathway 💬 45 genes, 108 drugs (DrugBank) and 112 diseases |
ADORA1 [4] ADORA1, PDE2A, PDE3A, PDE3B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
31 | Cortisol synthesis and secretion 💬 14 genes, 30 drugs (DrugBank) and 62 diseases |
PDE8A [2] PDE8A, PDE8B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
32 | Cortisol synthesis and secretion 💬 14 genes, 30 drugs (DrugBank) and 62 diseases |
PDE8A [2] PDE8A, PDE8B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
33 | Cortisol synthesis and secretion 💬 14 genes, 30 drugs (DrugBank) and 62 diseases |
PDE8A [2] PDE8A, PDE8B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
34 | Cortisol synthesis and secretion 💬 14 genes, 30 drugs (DrugBank) and 62 diseases |
PDE8A [2] PDE8A, PDE8B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
35 | Cortisol synthesis and secretion 💬 14 genes, 30 drugs (DrugBank) and 62 diseases |
PDE8A [2] PDE8A, PDE8B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
36 | Cushing syndrome 💬 21 genes, 43 drugs (DrugBank) and 66 diseases |
PDE11A [3] PDE11A, PDE8A, PDE8B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
37 | Cushing syndrome 💬 21 genes, 43 drugs (DrugBank) and 66 diseases |
PDE11A [3] PDE11A, PDE8A, PDE8B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
38 | Cushing syndrome 💬 21 genes, 43 drugs (DrugBank) and 66 diseases |
PDE11A [3] PDE11A, PDE8A, PDE8B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
39 | Cushing syndrome 💬 21 genes, 43 drugs (DrugBank) and 66 diseases |
PDE11A [3] PDE11A, PDE8A, PDE8B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
40 | Cushing syndrome 💬 21 genes, 43 drugs (DrugBank) and 66 diseases |
PDE11A [3] PDE11A, PDE8A, PDE8B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
41 | Cytokine-cytokine receptor interaction 💬 74 genes, 100 drugs (DrugBank) and 97 diseases |
GHR [1] GHR 💬 |
D02691 D02691 💬 |
Somatotropin | 002 [20] 2 , 3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬 |
42 | Glucagon signaling pathway 💬 13 genes, 18 drugs (DrugBank) and 78 diseases |
PDE3B [1] PDE3B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
43 | Glucagon signaling pathway 💬 13 genes, 18 drugs (DrugBank) and 78 diseases |
PDE3B [1] PDE3B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
44 | Glucagon signaling pathway 💬 13 genes, 18 drugs (DrugBank) and 78 diseases |
PDE3B [1] PDE3B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
45 | Glucagon signaling pathway 💬 13 genes, 18 drugs (DrugBank) and 78 diseases |
PDE3B [1] PDE3B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
46 | Glucagon signaling pathway 💬 13 genes, 18 drugs (DrugBank) and 78 diseases |
PDE3B [1] PDE3B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
47 | Growth hormone synthesis, secretion and action 💬 23 genes, 38 drugs (DrugBank) and 81 diseases |
GHR [1] GHR 💬 |
D02691 D02691 💬 |
Somatotropin | 002 [20] 2 , 3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬 |
48 | Insulin signaling pathway 💬 12 genes, 21 drugs (DrugBank) and 59 diseases |
PDE3B [1] PDE3B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
49 | Insulin signaling pathway 💬 12 genes, 21 drugs (DrugBank) and 59 diseases |
PDE3B [1] PDE3B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
50 | Insulin signaling pathway 💬 12 genes, 21 drugs (DrugBank) and 59 diseases |
PDE3B [1] PDE3B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
51 | Insulin signaling pathway 💬 12 genes, 21 drugs (DrugBank) and 59 diseases |
PDE3B [1] PDE3B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
52 | Insulin signaling pathway 💬 12 genes, 21 drugs (DrugBank) and 59 diseases |
PDE3B [1] PDE3B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
53 | JAK-STAT signaling pathway 💬 54 genes, 83 drugs (DrugBank) and 104 diseases |
GHR [1] GHR 💬 |
D02691 D02691 💬 |
Somatotropin | 002 [20] 2 , 3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬 |
54 | Metabolic pathways 💬 104 genes, 142 drugs (DrugBank) and 128 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
55 | Metabolic pathways 💬 104 genes, 142 drugs (DrugBank) and 128 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
56 | Metabolic pathways 💬 104 genes, 142 drugs (DrugBank) and 128 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
57 | Metabolic pathways 💬 104 genes, 142 drugs (DrugBank) and 128 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
58 | Metabolic pathways 💬 104 genes, 142 drugs (DrugBank) and 128 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
59 | Morphine addiction 💬 40 genes, 59 drugs (DrugBank) and 71 diseases |
ADORA1 [17] ADORA1, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
60 | Morphine addiction 💬 40 genes, 59 drugs (DrugBank) and 71 diseases |
ADORA1 [17] ADORA1, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
61 | Morphine addiction 💬 40 genes, 59 drugs (DrugBank) and 71 diseases |
ADORA1 [17] ADORA1, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
62 | Morphine addiction 💬 40 genes, 59 drugs (DrugBank) and 71 diseases |
ADORA1 [17] ADORA1, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
63 | Morphine addiction 💬 40 genes, 59 drugs (DrugBank) and 71 diseases |
ADORA1 [17] ADORA1, PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
64 | Neuroactive ligand-receptor interaction 💬 146 genes, 309 drugs (DrugBank) and 144 diseases |
ADORA1 [2] ADORA1, ADORA2A 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
65 | Neuroactive ligand-receptor interaction 💬 146 genes, 309 drugs (DrugBank) and 144 diseases |
ADORA1 [2] ADORA1, ADORA2B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
66 | Neuroactive ligand-receptor interaction 💬 146 genes, 309 drugs (DrugBank) and 144 diseases |
ADORA1 [2] ADORA1, ADORA2B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
67 | Neuroactive ligand-receptor interaction 💬 146 genes, 309 drugs (DrugBank) and 144 diseases |
ADORA1 [2] ADORA1, ADORA2B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
68 | Neuroactive ligand-receptor interaction 💬 146 genes, 309 drugs (DrugBank) and 144 diseases |
ADORA1 [2] ADORA1, ADORA2B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
69 | Neuroactive ligand-receptor interaction 💬 146 genes, 309 drugs (DrugBank) and 144 diseases |
GHR [1] GHR 💬 |
D02691 D02691 💬 |
Somatotropin | 002 [20] 2 , 3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬 |
70 | Olfactory transduction 💬 4 genes, 3 drugs (DrugBank) and 12 diseases |
PDE1A [4] PDE1A, PDE1B, PDE1C, PDE2A 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
71 | Olfactory transduction 💬 4 genes, 3 drugs (DrugBank) and 12 diseases |
PDE1A [4] PDE1A, PDE1B, PDE1C, PDE2A 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
72 | Olfactory transduction 💬 4 genes, 3 drugs (DrugBank) and 12 diseases |
PDE1A [4] PDE1A, PDE1B, PDE1C, PDE2A 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
73 | Olfactory transduction 💬 4 genes, 3 drugs (DrugBank) and 12 diseases |
PDE1A [4] PDE1A, PDE1B, PDE1C, PDE2A 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
74 | Olfactory transduction 💬 4 genes, 3 drugs (DrugBank) and 12 diseases |
PDE1A [4] PDE1A, PDE1B, PDE1C, PDE2A 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
75 | Parathyroid hormone synthesis, secretion and action 💬 19 genes, 40 drugs (DrugBank) and 58 diseases |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
76 | Parathyroid hormone synthesis, secretion and action 💬 19 genes, 40 drugs (DrugBank) and 58 diseases |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
77 | Parathyroid hormone synthesis, secretion and action 💬 19 genes, 40 drugs (DrugBank) and 58 diseases |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
78 | Parathyroid hormone synthesis, secretion and action 💬 19 genes, 40 drugs (DrugBank) and 58 diseases |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
79 | Parathyroid hormone synthesis, secretion and action 💬 19 genes, 40 drugs (DrugBank) and 58 diseases |
PDE4A [4] PDE4A, PDE4B, PDE4C, PDE4D 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
80 | Parkinson disease 💬 21 genes, 64 drugs (DrugBank) and 63 diseases |
ADORA2A [1] ADORA2A 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
81 | PI3K-Akt signaling pathway 💬 70 genes, 106 drugs (DrugBank) and 116 diseases |
GHR [1] GHR 💬 |
D02691 D02691 💬 |
Somatotropin | 002 [20] 2 , 3 , 13, 19, 46, 74, 75, 76, 78, 96, 113, 187, 191, 193, 195, 236, 265, 274, 276, 299 💬 |
82 | Progesterone-mediated oocyte maturation 💬 14 genes, 32 drugs (DrugBank) and 37 diseases |
PDE3B [1] PDE3B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
83 | Progesterone-mediated oocyte maturation 💬 14 genes, 32 drugs (DrugBank) and 37 diseases |
PDE3B [1] PDE3B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
84 | Progesterone-mediated oocyte maturation 💬 14 genes, 32 drugs (DrugBank) and 37 diseases |
PDE3B [1] PDE3B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
85 | Progesterone-mediated oocyte maturation 💬 14 genes, 32 drugs (DrugBank) and 37 diseases |
PDE3B [1] PDE3B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
86 | Progesterone-mediated oocyte maturation 💬 14 genes, 32 drugs (DrugBank) and 37 diseases |
PDE3B [1] PDE3B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
87 | Purine metabolism 💬 30 genes, 31 drugs (DrugBank) and 68 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
88 | Purine metabolism 💬 30 genes, 31 drugs (DrugBank) and 68 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
89 | Purine metabolism 💬 30 genes, 31 drugs (DrugBank) and 68 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
90 | Purine metabolism 💬 30 genes, 31 drugs (DrugBank) and 68 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
91 | Purine metabolism 💬 30 genes, 31 drugs (DrugBank) and 68 diseases |
PDE10A [16] PDE10A, PDE11A, PDE1A, PDE1B, PDE1C, PDE2A, PDE3A, PDE3B, PDE4A, PDE4B, PDE4C, PDE4D, PDE7A, PDE7B, PDE8A, PDE8B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
92 | Rap1 signaling pathway 💬 40 genes, 91 drugs (DrugBank) and 82 diseases |
ADORA2A [1] ADORA2A 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
93 | Rap1 signaling pathway 💬 40 genes, 91 drugs (DrugBank) and 82 diseases |
ADORA2B [1] ADORA2B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
94 | Rap1 signaling pathway 💬 40 genes, 91 drugs (DrugBank) and 82 diseases |
ADORA2B [1] ADORA2B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
95 | Rap1 signaling pathway 💬 40 genes, 91 drugs (DrugBank) and 82 diseases |
ADORA2B [1] ADORA2B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
96 | Rap1 signaling pathway 💬 40 genes, 91 drugs (DrugBank) and 82 diseases |
ADORA2B [1] ADORA2B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
97 | Regulation of lipolysis in adipocytes 💬 13 genes, 65 drugs (DrugBank) and 61 diseases |
ADORA1 [2] ADORA1, PDE3B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
98 | Regulation of lipolysis in adipocytes 💬 13 genes, 65 drugs (DrugBank) and 61 diseases |
ADORA1 [2] ADORA1, PDE3B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
99 | Regulation of lipolysis in adipocytes 💬 13 genes, 65 drugs (DrugBank) and 61 diseases |
ADORA1 [2] ADORA1, PDE3B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
100 | Regulation of lipolysis in adipocytes 💬 13 genes, 65 drugs (DrugBank) and 61 diseases |
ADORA1 [2] ADORA1, PDE3B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
101 | Regulation of lipolysis in adipocytes 💬 13 genes, 65 drugs (DrugBank) and 61 diseases |
ADORA1 [2] ADORA1, PDE3B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
102 | Renin secretion 💬 28 genes, 77 drugs (DrugBank) and 105 diseases |
ADORA1 [6] ADORA1, PDE1A, PDE1B, PDE1C, PDE3A, PDE3B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
103 | Renin secretion 💬 28 genes, 77 drugs (DrugBank) and 105 diseases |
ADORA1 [6] ADORA1, PDE1A, PDE1B, PDE1C, PDE3A, PDE3B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
104 | Renin secretion 💬 28 genes, 77 drugs (DrugBank) and 105 diseases |
ADORA1 [6] ADORA1, PDE1A, PDE1B, PDE1C, PDE3A, PDE3B 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
105 | Renin secretion 💬 28 genes, 77 drugs (DrugBank) and 105 diseases |
ADORA1 [6] ADORA1, PDE1A, PDE1B, PDE1C, PDE3A, PDE3B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
106 | Renin secretion 💬 28 genes, 77 drugs (DrugBank) and 105 diseases |
ADORA1 [6] ADORA1, PDE1A, PDE1B, PDE1C, PDE3A, PDE3B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
107 | Sphingolipid signaling pathway 💬 28 genes, 45 drugs (DrugBank) and 69 diseases |
ADORA1 [1] ADORA1 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
108 | Sphingolipid signaling pathway 💬 28 genes, 45 drugs (DrugBank) and 69 diseases |
ADORA1 [1] ADORA1 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
109 | Sphingolipid signaling pathway 💬 28 genes, 45 drugs (DrugBank) and 69 diseases |
ADORA1 [1] ADORA1 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
110 | Sphingolipid signaling pathway 💬 28 genes, 45 drugs (DrugBank) and 69 diseases |
ADORA1 [1] ADORA1 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
111 | Sphingolipid signaling pathway 💬 28 genes, 45 drugs (DrugBank) and 69 diseases |
ADORA1 [1] ADORA1 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
112 | Taste transduction 💬 30 genes, 78 drugs (DrugBank) and 65 diseases |
PDE1A [3] PDE1A, PDE1B, PDE1C 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
113 | Taste transduction 💬 30 genes, 78 drugs (DrugBank) and 65 diseases |
PDE1A [3] PDE1A, PDE1B, PDE1C 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
114 | Taste transduction 💬 30 genes, 78 drugs (DrugBank) and 65 diseases |
PDE1A [3] PDE1A, PDE1B, PDE1C 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
115 | Taste transduction 💬 30 genes, 78 drugs (DrugBank) and 65 diseases |
PDE1A [3] PDE1A, PDE1B, PDE1C 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
116 | Taste transduction 💬 30 genes, 78 drugs (DrugBank) and 65 diseases |
PDE1A [3] PDE1A, PDE1B, PDE1C 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |
117 | Vascular smooth muscle contraction 💬 30 genes, 71 drugs (DrugBank) and 65 diseases |
ADORA2A [1] ADORA2A 💬 |
D02017 D02017 💬 |
Theophylline | 236 [2] 236, 299 💬 |
118 | Vascular smooth muscle contraction 💬 30 genes, 71 drugs (DrugBank) and 65 diseases |
ADORA2B [1] ADORA2B 💬 |
D00371 D00371 💬 |
Theophylline | 236 [2] 236, 299 💬 |
119 | Vascular smooth muscle contraction 💬 30 genes, 71 drugs (DrugBank) and 65 diseases |
ADORA2B [1] ADORA2B 💬 |
D01712 D01712 💬 |
Theophylline | 236 [2] 236, 299 💬 |
120 | Vascular smooth muscle contraction 💬 30 genes, 71 drugs (DrugBank) and 65 diseases |
ADORA2B [1] ADORA2B 💬 |
D06103 D06103 💬 |
Theophylline | 236 [2] 236, 299 💬 |
121 | Vascular smooth muscle contraction 💬 30 genes, 71 drugs (DrugBank) and 65 diseases |
ADORA2B [1] ADORA2B 💬 |
D06104 D06104 💬 |
Theophylline | 236 [2] 236, 299 💬 |